Interfakultäres Institut für Mikrobiologie und Infektionsmedizin


Original Publications

1. Javed M, Ueltzhöffer V, Heinrich M, Siegrist HJ, Wildermuth R, Lorenz F, Neher RA, Willmann M. “Colistin susceptibility test evaluation of multiple-resistance level Pseudomonas aeruginosa isolates generated in a morbidostat device”. Journal of Antimicrobial Chemotherapy, accepted

2. Wendel AF, Meyer S, Deenen R, Köhrer K, Kolbe-Busch S, Pfeffer K, Willmann M, Kaasch AJ, MacKenzie CR. Long-Term, Low-Frequency Cluster of a German-Imipenemase-1-Producing Enterobacter hormaechei ssp. steigerwaltii ST89 in a Tertiary Care Hospital in Germany.“ Microbial Drug Resistance, 2018

3. Górska A, Peter S, Willmann M, Autenrieth I, Schlaberg R, Huson DH. “Dynamics of the human gut phageome during antibiotic treatment.” Computational Biology and Chemistry, 2018 

4. Peter S, Bezdan D, Oberhettinger P, Vogel W, Dörfel D, Dick J, Marschal M, Liese J, Weidenmaier C, Autenrieth I, Ossowski S, Willmann M. „Whole-genome sequencing enabling the detection of a colistin-resistant hypermutating Citrobacter werkmanii strain harbouring a novel metallo-β-lactamase VIM-48.” International Journal of Antimicrobial Agents, 2018

5. Peter S, Oberhettinger P, Schuele L, Dinkelacker A, Vogel W, Dörfel D, Bezdan D, Ossowski S, Marschal M, Liese J, Willmann M. „Genomic characterisation of clinical and environmental Pseudomonas putida group strains and determination of their role in the transfer of antimicrobial resistance genes to Pseudomonas aeruginosa.” BMC Genomics, 2017

6. Whiteley L, Haug M, Klein K, Willmann M, Bohn E, Chiantia S, Schwarz S. „Cholesterol and host cell surface proteins contribute to cell-cell fusion induced by the Burkholderia type VI secretion system 5.” PLoS One, 2017

7. Dößelmann B, Willmann M*, Steglich M, Bunk B, Nübel U, Peter S, Neher RA. „Rapid and Consistent Evolution of Colistin Resistance in Extensively Drug-Resistant Pseudomonas aeruginosa during Morbidostat Culture.” Antimicrobial Agents and Chemotherapy, 2017            *shared first author

8. Marschal M, Bachmaier J, Autenrieth I, Oberhettinger P, Willmann M, Peter S. „Evaluation of the Accelerate Pheno System for Fast Identification and Antimicrobial Susceptibility Testing from Positive Blood Cultures in Bloodstream Infections Caused by Gram-Negative Pathogens.” Journal of Clinical Microbiology, 2017

9. Huson DH, Steel M, El-Hadidi M, Mitra S, Peter S, Willmann M. “A simple statistical test of taxonomic or functional homogeneity using replicated microbiome sequencing samples.” Journal of Biotechnology, 2017

10. Wendel AF, Kaase M, Autenrieth IB, Peter S, Oberhettinger P, Rieber H, Pfeffer K, MacKenzie CR, Willmann M. „Protracted Regional Dissemination of GIM-1-Producing Serratia marcescens in Western Germany.” Antimicrobial Agents and Chemotherapy, 2017

11. Hamprecht A, Rohde AM, Behnke M, Feihl S, Gastmeier P, Gebhardt F, Kern WV, Knobloch JK, Mischnik A, Obermann B, Querbach C, Peter S, Schneider C, Schröder W, Schwab F, Tacconelli E, Wiese-Posselt M, Wille T, Willmann M, Seifert H, Zweigner J; DZIF-ATHOS Study Group. „Colonization with third-generation cephalosporin-resistant Enterobacteriaceae on hospital admission: prevalence and risk factors.” Journal of Antimicrobial Chemotherapy, 2016

12. Zipperer A, Konnerth MC, Laux C, Berscheid A, Janek D, Weidenmaier C, Burian M, Schilling NA, Slavetinsky C, Marschal M, Willmann M, Kalbacher H, Schittek B, Brötz-Oesterhelt H, Grond S, Peschel A, Krismer B. „Human commensals producing a novel antibiotic impair pathogen colonization.” Nature, 2016

13. Willmann M, El-Hadidi M, Huson DH, Schütz M, Weidenmaier C, Autenrieth IB, Peter S. „Antibiotic selection pressure determination through sequence-based metagenomics. Antimicrobial Agents and Chemotherapy, 2015

14. Willmann M, Bezdan D, Zapata L, Susak H, Vogel W, Schröppel K, Liese J, Weidenmaier C, Autenrieth IB, Ossowski S, Peter S. "Analysis of a long-term outbreak of extensively drug-resistant Pseudomonas aeruginosa: a molecular epidemiological study." Journal of Antimicrobial Chemotherapy, 2015                 

15. Willmann M, Klimek AM, Vogel W, Liese J, Marschal M, Autenrieth IB, Peter S, Buhl M: "Clinical and treatment-related risk factors for nosocomial colonisation with extensively drug-resistant Pseudomonas aeruginosa in a haematological patient population: a matched case control study." BMC Infectious Diseases, 2014

16. Ahmed AM, Pinheiro MM, Divis PC, Siner A, Zainudin R, Wong IT, Lu CW, Singh-Khaira SK, Millar SB, Lynch S, Willmann M, Singh B, Krishna S, Cox-Singh J. “Disease progression in Plasmodium knowlesi malaria is linked to variation in invasion gene family members.“ PLoS Neglected Tropical Diseases, 2014

17. Peter S, Wolz C, Kaase M, Marschal M, Schulte B, Vogel W, Autenrieth I, Willmann M. „Emergence of Citrobacter freundii carrying IMP-8 metallo-β-lactamase in Germany.“ New Microbes and New Infections, 2014

18. Peter S, Lacher A, Marschal M, Hölzl F, Buhl M, Autenrieth I, Kaase M, Willmann M. „Evaluation of phenotypic detection methods for metallo-β-lactamases (MBLs) in clinical isolates of Pseudomonas aeruginosa.“ European Journal of Clinical Microbiology & Infectious Diseases, 2014

19. Willmann M, Kuebart I, Marschal M, Schröppel K, Vogel W, Flesch I, Markert U, Autenrieth IB, Hölzl F, Peter S: "Effect of metallo-beta-lactamase production and multidrug resistance on clinical outcomes in patients with Pseudomonas aeruginosa bloodstream infection: a retrospective cohort study." BMC Infectious Diseases, 2013

20. Willmann M, Marschal M, Hölzl F, Schröppel K, Autenrieth IB, Peter S: "Time series analysis as a tool to predict the impact of antimicrobial restriction in antibiotic stewardship programs using the example of multidrug-resistant Pseudomonas aeruginosa." Antimicrobial Agents and Chemotherapy, 2013 

21. Willmann M, Kuebart I, Vogel W, Flesch I, Markert U, Marschal M, Schröppel K, Autenrieth IB, Hölzl F, Peter S: "Time to positivity as prognostic tool in patients with Pseudomonas aeruginosa bloodstream infection." Journal of Infection, 2013

22. Willmann M, Ahmed A, Siner A, Wong IT, Woon LC, Singh B, Krishna S, Cox-Singh J. “Laboratory markers of disease severity in Plasmodium knowlesi infection: a case control study.“ Malaria Journal, 2013

23. Verrier SE, Willmann M, Wenzel D, Winter U, von Mollard GF, Söling HD. Members of a mammalian SNARE complex interact in the endoplasmic reticulum in vivo and are found in COPI vesicles.“ European Journal of Cell Biology, 2008


1. Willmann M, Peter S. „Translational metagenomics and the human resistome: confronting the menace of the new millennium.” Journal of Molecular Medicine, 2017

2. Buhl M, Peter S, Willmann M. “Prevalence and risk factors associated with colonization and infection of extensively drug-resistant Pseudomonas aeruginosa: a systemic review.” Expert Review of Anti-infective Therapy, 2015